Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study
NCT ID: NCT04039243
Last Updated: 2026-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
90 participants
INTERVENTIONAL
2019-09-27
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Intervention for Children at Risk for Anxiety
NCT00865306
Brief Behavioral Treatment for Anxiety in Young Children
NCT02051192
Evaluating the Effectiveness of Early Cognitive Behavioral Therapy With or Without Parental Involvement in Treating Anxious Children
NCT00557648
Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety
NCT04157296
School-Based Treatment for Early Childhood Anxiety
NCT04811482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Treatment
Up to 12 sessions of Parent-Child CBT using an adaptation of the Being Brave protocol
Being Brave
Up to 12 weekly sessions
Parent Education
Parents receive educational materials about how to help young children overcome shyness and anxiety
Parent Education
Parents receive educational materials about helping children overcome shyness and fear
Monitoring
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Being Brave
Up to 12 weekly sessions
Parent Education
Parents receive educational materials about helping children overcome shyness and fear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The parents are able to speak, understand, and read English
* The child must have a working knowledge of English.
Exclusion Criteria
* The child has disruptive behavior so severe as to interfere with participation in intervention sessions
* The child has a different primary disorder for which CBT for anxiety is inappropriate (e.g. severe depression, depression in the mother, significant medical disorder).
21 Months
47 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina R. Hirshfeld-Becker
Co-Director, MGH Child CBT Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dina Hirshfeld-Becker, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018P000376
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.